- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01102036
Effects of Cultura Yoghurt in Relation to Transit Time and Digestive Discomfort in Healthy Women and Men
August 25, 2011 updated by: Birgitta Sundberg, Good Food Practice, Sweden
Effects of Cultura Yoghurt in Relation to Transit Time and Digestive Discomfort During 2 Weeks of Treatment in Comparison to Placebo in Healthy Women and Men
The aim of this study is to determine the effect of cultura yoghurt on transit time and digestive discomfort during 2 weeks of treatment in comparison to placebo in healthy women and men.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Transit time is the time it takes for a substance to pass through the gut. The major part of the transit is spent in the large bowel is therefore mainly a colonic event. It has been observed that slow transit time is associated with high prevalence of large bowel disorders. The objectives of this study is to:
- determine the effect on mean transit time after 2 weeks intake of a investigational products using radio-opaque sulphate impregnated polyethylene pellets as markers.
- determine effect of investigational products on total symptom score according to Bristol Stool Form (BSF)
- determine effect of investigational products in gastrointestinal symptoms
- determine safety of intake of the investigational products
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Uppsala, Sweden, 751 83
- Good Food Practice
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 56 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Female and Males
- Healthy
- BMI 19-29 at visit 1
- Age 18 and 60 years at visit 1
- Defecation 3-4 times per week or every second to third day (Bristol Stool Form) during the run-in
- Transit time 35 and 72 hours calculated from the abdominal X-ray at visit 3
- Signed written informed consent
Exclusion Criteria:
- Use of probiotics food or supplements during the study
- Past history of digestive disease
- Previous complicated GI surgery
- Oral use of antimicrobial medication or antimicrobial prophylaxis 4 weeks prior to screening visit
- Use of laxatives (medication or dietary supplements) during the study.
- Pregnant or lactating or wish to become pregnant during the period of the study
- Lack of suitability for participation in the trial, for any reason, as judged by the personnel at KPL Good Food Practice AB
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Yoghurt without probiotics
Yoghurt without probiotic bacteria
|
Yoghurt without probiotics
|
|
Active Comparator: Cultura yoghurt
Cultura yoghurt with L casei F19, acidophilus La5 adn B lactis Bb 12
|
2 weeks consumption,250 ml/day
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in transit time between treatments
Time Frame: February 2010-June 2010
|
To determine the effect on mean transit time after 2 weeks intake of investigational products using radio-opaque barium sulphate impregnated polyethylen capsules.
These capsules will be consumed during 3 days and thereafter an x-ray image will be taken over the bowel.
The capsulese will then be calculated to determine the colonic transit time
|
February 2010-June 2010
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change between treatments on Bristol Stool Form (BSF)symptoms scores
Time Frame: February 2010-June2010
|
To determine the effect of Cultura yoghurt on the total symptom score according to Bristol Stool Form (BSF) scale during 2 weeks of treatment in comparison to placebo in healthy women and men
|
February 2010-June2010
|
|
Change between treatments on gastrointestinal symptoms according to Bristol Stool Form
Time Frame: February 2010-June 2010
|
To determine the effect of Cultura yoghurt on gastrointestinal symptoms according to the Bristol Stool Form (BSF) after 2 weeks treatment of investigational products
|
February 2010-June 2010
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Lars Magnusson, CEO, Good Food Practice, Uppsala, Sweden
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2010
Primary Completion (Actual)
May 1, 2010
Study Completion (Actual)
June 1, 2010
Study Registration Dates
First Submitted
April 8, 2010
First Submitted That Met QC Criteria
April 9, 2010
First Posted (Estimate)
April 12, 2010
Study Record Updates
Last Update Posted (Estimate)
August 26, 2011
Last Update Submitted That Met QC Criteria
August 25, 2011
Last Verified
April 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- C-X-Ray U-09-017
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Constipation
-
Peking Union Medical College HospitalInstitute of Process Engineering, Chinese Academy of SciencesNot yet recruitingChronic Constipation | Constipation - Functional | Fecal Microbiota TransplantationChina
-
Hamilton Health Sciences CorporationNot yet recruitingConstipation | Constipation - Functional | Constipation AggravatedCanada
-
Singapore Institute of TechnologyNot yet recruitingConstipation | Diet Modification | Constipation-predominant Irritable Bowel Syndrome | Diet Therapy | Constipation - Functional | Constipation Chronic Idiopathic | Constipation, Signs and Symptoms, Digestive | Dietary Fiber | Dietary Fibers | Constipation Predominant Irritable Bowel Syndrome | Dietary and... and other conditionsSingapore
-
Institute of Medical Sciences and SUM HospitalNot yet recruitingFunctional Constipation | Constipation - Functional | Constipation Chronic Idiopathic | Fecal Impaction | Pediatric Functional ConstipationIndia
-
Peking Union Medical College HospitalRecruitingChronic Constipation | Constipation - Functional | Fecal Microbiota Transplantation (FMT)China
-
SK Life Science, Inc.CompletedChronic Constipation | Functional ConstipationUnited States
-
Hong Kong Metropolitan UniversityNot yet recruitingConstipation | Constipation Drug Induced | Psychiatric Drug Induced ConstipationHong Kong
-
usMIMA S.L.CompletedConstipation | Constipation Chronic Idiopathic | Constipation; NeurogenicSpain, United Kingdom
-
Hong Kong Metropolitan UniversityHospital Authority, Hong KongRecruitingConstipation | Constipation Drug Induced | Psychiatric Drug Induced ConstipationHong Kong
-
Cairo UniversityUnknownChronic Idiopathic Constipation | Functional ConstipationEgypt
Clinical Trials on Yoghurt without probiotics
-
Kutahya Health Sciences UniversityMedipol UniversityCompletedAppetitive Behavior | SatietyTurkey
-
Yonsei UniversityCompletedLDL-cholesterol Level 130-159mg/dL
-
Maastricht University Medical CenterCompleted
-
Maastricht University Medical CenterWageningen University and ResearchCompleted
-
Universiti Sains MalaysiaSYNBIO TECH INC. Kaohsiung TaiwanCompleted
-
Danone ResearchCompleted
-
Good Food Practice, SwedenCompletedQuality of Life | Irritable Bowel Syndrome | Relief of Irritable Bowel Syndrome SymptomsSweden
-
University of ValladolidDanone Institute International; University of SevilleCompletedImmune System | Innate Inflammatory Response
-
Rijnstate HospitalWageningen University; NIZO Food Research; Allergologiepraktijk Arnhem/Radboud... and other collaboratorsCompletedHay Fever | Birch Pollen AllergyNetherlands
-
Hangzhou Wei Chuan Foods Co., Ltd.Completed